首页|温阳化湿逐瘀汤治疗盆腔炎性疾病后遗症寒湿瘀滞型慢性盆腔痛的临床效果观察

温阳化湿逐瘀汤治疗盆腔炎性疾病后遗症寒湿瘀滞型慢性盆腔痛的临床效果观察

扫码查看
目的:研究温阳化湿逐瘀汤治疗盆腔炎性疾病后遗症寒湿瘀滞型慢性盆腔痛的临床效果和安全性.方法:将64例寒湿瘀滞型慢性盆腔痛患者随机分为两组,每组32例:观察组接受温阳化湿逐瘀汤治疗,对照组接受桂枝茯苓胶囊治疗.对比两组治疗后VAS评分,中医证候评分及盆腔体征评分变化.结果:治疗12周后,温阳化湿逐瘀汤组总有效率96.9%,高于桂枝茯苓胶囊组的75.0%(x2=16.74,P<0.05);两组各时间节点VAS评分、中医证候评分及盆腔体征评分均较治疗前降低,治疗后4、8d和12周观察组VAS评分下降程度(1.46±1.62、2.50±1.62、3.34±1.80)均大于对照组(0.65±0.65、1.31±0.86、1.68±1.02)、同时中医证候和盆腔体征改善程度也明显优于对照组(P<0.05).结论:温阳化湿逐瘀汤治疗寒湿瘀滞型慢性盆腔痛临床疗效确切,可以有效改善患者疼痛症状、盆腔体征,且具备安全性.
Clinical effect of Wenyang huashi zhuyu decoction for treating the chronic pelvic pain of the cold and damp stasis type of patients caused by the sequelae of their pelvic inflammatory disease
Objective:To investigate the clinical efficacy and safety of Wenyang huashi zhuyu decoction for treating the chronic pelvic pain(CPP)of the cold and damp stasis type of patients caused by the sequelae of pelvic inflammatory disease(SPID).Methods:64 patients with the cold and damp stasis type CPP caused by SPID were divided into two groups(32 patients in each group)randomly.The patients in the observation group were treated with Wenyang huashi zhuyu decoction,while the patients in the control group were treated with Guizhi poria capsule.The scores of visual an-alogue scale(VAS)and the traditional Chinese medicine(TCM)syndrome,and the change of the pelvic sign score of the patients after treatment were compared between the two groups.Results:The total effective rate(96.9%)of the patients in the observation group in 12 weeks after treatment was significantly higher than that(75.0%)of the patients in the control group(X2=16.74,P<0.05).The scores of VAS,TCM syndrome and pelvic signs of the patients in the two groups at each time point after treatment had decreased significantly,and the decrease degree of the VAS score at each time point(1.46±1.62 points,2.50±1.62 points and 3.34±1.80 points)of the patients in the observation group were significantly more than those(0.65±0.65 points,1.31±0.86 points and 1.68±1.02 points)of the patients in the control group.At the same time,the improvement of the scores of TCM syndromes and pelvic signs of the patients in the observation group were significantly better than those of the patients in the control group(P<0.05).Conclusion:The Wenyang huashi zhuyu decoction for treating the cold and damp stasis type CPP of the patients caused by SPID has the definite clinical efficacy,which can alleviate the pain symptoms and pelvic signs of the patients,and with good safety.

Wenyang huashi zhuyu decoctionChronic pelvic painPain score

封洪君、季晓黎

展开 >

成都中医药大学附属医院(610075)

慢性盆腔痛 温阳化湿逐瘀汤 疼痛评分

成都中医药大学附属医院2020年科技发展基金

202J02

2024

中国计划生育学杂志
国家人口计生委科学技术研究所

中国计划生育学杂志

CSTPCD
影响因子:1.759
ISSN:1004-8189
年,卷(期):2024.32(9)